| Antibody or antibody fragments: implications for molecular imaging and targeted therapy of solid tumors KT Xenaki, S Oliveira, PMP van Bergen En Henegouwen Frontiers in immunology 8, 1287, 2017 | 276 | 2017 |
| Homogeneous tumor targeting with a single dose of HER2-targeted albumin-binding domain-fused nanobody-drug conjugates results in long-lasting tumor remission in mice KT Xenaki, B Dorresteijn, JA Muns, K Adamzek, S Doulkeridou, ... Theranostics 11 (11), 5525, 2021 | 50 | 2021 |
| Imaging of tumor spheroids, dual-isotope SPECT, and autoradiographic analysis to assess the tumor uptake and distribution of different nanobodies I Beltrán Hernández, R Rompen, R Rossin, KT Xenaki, EA Katrukha, ... Molecular Imaging and Biology 21, 1079-1088, 2019 | 30 | 2019 |
| Implications for tetraspanin-enriched microdomain assembly based on structures of CD9 with EWI-F W Oosterheert, KT Xenaki, V Neviani, W Pos, S Doulkeridou, ... Life Science Alliance 3 (11), 2020 | 27 | 2020 |
| Dual targeting of endothelial and cancer cells potentiates in vitro nanobody-targeted photodynamic therapy V Mashayekhi, KT Xenaki, PMP van Bergen En Henegouwen, S Oliveira Cancers 12 (10), 2732, 2020 | 19 | 2020 |
| Site‐specific functionality and tryptophan mimicry of lipidation in tetraspanin CD9 V Neviani, S van Deventer, TP Wörner, KT Xenaki, M van de Waterbeemd, ... The FEBS journal 287 (24), 5323-5344, 2020 | 17 | 2020 |
| Development of in vitro-grown spheroids as a 3D tumor model system for solid-state NMR spectroscopy R Damman, A Lucini Paioni, KT Xenaki, I Beltrán Hernández, ... Journal of Biomolecular NMR 74 (8), 401-412, 2020 | 15 | 2020 |
| Antibody or antibody fragments: implications for molecular imaging and targeted therapy of solid tumors, Front. Immunol.(2017) KT Xenaki, S Oliveira, PMPB en Henegouwen | 11 | 2017 |
| Homogeneous tumor targeting with a single dose of HER2-targeted albumin-binding domain-fused nanobody-drug conjugates results in long-lasting tumor remission in mice … KT Xenaki, B Dorrestijn, JA Muns, K Adamzek, S Doulkeridou, H Houthoff, ... | 9 | |
| Multifaceted activities of seven nanobodies against complement C4b KI De la O Becerra, W Oosterheert, RM van den Bos, KT Xenaki, ... The Journal of Immunology 208 (9), 2207-2219, 2022 | 7 | 2022 |
| Antibody or antibody fragments: implications for molecular imaging and targeted therapy of solid tumors. Front Immunol. 2017; 8: 1287 KT Xenaki, S Oliveira, PMP van Bergen En Henegouwen | 6 | 2017 |
| Site-specific functionality of lipidation in tetraspanin CD9 revealed by tryptophan mimicry V Neviani, S van Deventer, TP Wörner, KT Xenaki, M van de Waterbeemd, ... Unravelling the molecular mechanisms of tetraspanin CD9, 109, 2019 | 1 | 2019 |
| Structural basis of phage transcriptional regulation C He, G He, Y Feng Structure, 2024 | | 2024 |
| Multifaceted Activities of Seven Nanobodies against Complement C4b I Karla, W Oosterheert, RM van den Bos, KT Xenaki, JH Lorent, M Ruyken, ... The Journal of Immunology Author Choice 208 (9), 2207, 2022 | | 2022 |
| Correction to: Imaging of Tumor Spheroids, Dual-Isotope SPECT, and Autoradiographic Analysis to Assess the Tumor Uptake and Distribution of Different Nanobodies IB Hernández, R Rompen, R Rossin, KT Xenaki, EA Katrukha, K Nicolay, ... Molecular imaging and biology 22 (1), 217, 2020 | | 2020 |
| Expression and purification of human full-length tetraspanin CD9 and characterization of high-affinity nanobodies for structural studies V Neviani, KT Xenaki, RNP Rodenburg, S Doulkeridou, S Huisman, ... Unravelling the molecular mechanisms of tetraspanin CD9, 29, 2019 | | 2019 |
